Article ; Online: Reproductive health and hemostatic issues in women and girls with congenital factor VII deficiency: A systematic review.
Journal of thrombosis and haemostasis : JTH
2022 Volume 20, Issue 12, Page(s) 2758–2772
Abstract: Background: Congenital factor VII (FVII) deficiency is an inherited bleeding disorder, with heterogenous bleeding symptoms. Women with FVII deficiency face hemostatic challenges during menstruation, ovulation, and childbirth. This systematic review ... ...
Abstract | Background: Congenital factor VII (FVII) deficiency is an inherited bleeding disorder, with heterogenous bleeding symptoms. Women with FVII deficiency face hemostatic challenges during menstruation, ovulation, and childbirth. This systematic review evaluated prevalence and management of bleeding symptoms associated with gynecological and obstetric issues in women with FVII deficiency. Methods: Databases (BIOSIS Previews, Current Contents Search, Embase, and MEDLINE) were searched for studies reporting FVII deficiency and gynecological or obstetric issues in women. Articles were screened using Joanna Briggs Institute checklists and relevant data extracted. Results: One hundred fourteen women were identified from 62 publications. Forty-six women had severe deficiency (FVII:C < 5% or <5 IU/dl). Heavy menstrual bleeding (HMB) was the most common bleeding symptom (n = 94; 82%); hospitalization and urgent medical/surgical interventions for acute HMB episodes were required in 16 women (14%). Seven women reported ovarian bleeding (6%); other bleeding symptoms varied. Patient management was inconsistent and included hemostatic and hormonal treatments. Only four women (7%) reporting vaginal bleeding during pregnancy. Postpartum hemorrhage (PPH) occurred following 12/45 deliveries (27%; 5 [42%] requiring blood transfusion) and was not necessarily prevented by prophylaxis (8 women). Conclusion: Women with congenital FVII deficiency have an increased risk of HMB, ovarian bleeding, and PPH, impacting quality of life. Recognition of a bleeding disorder as the cause is often delayed. Management of bleeding complications is heterogeneous due to lack of treatment guidelines. Harmonizing severity classification of FVII deficiency may help standardize treatment strategies and development of specific guidelines for these women. |
---|---|
MeSH term(s) | Pregnancy ; Female ; Humans ; Factor VII Deficiency/complications ; Factor VII Deficiency/diagnosis ; Hemostatics/therapeutic use ; Quality of Life ; Reproductive Health ; Factor VII ; Menorrhagia ; Postpartum Hemorrhage/diagnosis ; Postpartum Hemorrhage/epidemiology ; Postpartum Hemorrhage/therapy |
Chemical Substances | Hemostatics ; Factor VII (9001-25-6) |
Language | English |
Publishing date | 2022-09-08 |
Publishing country | England |
Document type | Systematic Review ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2112661-6 |
ISSN | 1538-7836 ; 1538-7933 |
ISSN (online) | 1538-7836 |
ISSN | 1538-7933 |
DOI | 10.1111/jth.15872 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5805: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 295: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.